Navigation Links
Veracyte, Inc. Announces Third Quarter 2013 Financial Results
Date:11/25/2013

  • Net loss for the third quarter of 2013 was $6.3 million, or $6.59 per common share, compared to a net loss of $4.9 million, or $7.49 per common share for the same period in 2012.
  • Conference Call DetailsVeracyte will host a live conference call and webcast today at 5 p.m. Eastern Time to discuss the company's financial results and provide a general business update. The live webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the company's website at least 15 minutes prior to the live webcast to ensure adequate time for any necessary software download. Alternatively, please call (855) 541-0980 (U.S.) or (970) 315-0440 (international) to listen to the live conference call. The conference ID number for the live call is 98673982. Please dial in approximately 10 minutes prior to the call. The webcast will be available on the company's website for 14 days approximately two hours following completion of the call.

    About Veracyte, Inc.Veracyte is focused on discovering, developing and commercializing molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient care, thus helping patients avoid unnecessary invasive procedures while reducing healthcare costs. Veracyte's first commercial solution, the Afirma Thyroid FNA Analysis, includes the Gene Expression Classifier (GEC). Over 525,000 fine needle aspiration (FNA) biopsies are performed each year in the United States on thyroid nodules suspicious for cancer, with up to 30% of FNAs yielding indeterminate results using cytopathology alone. Traditionally, most of these patients have undergone surgery to remove all or part of their thyroids, yet in 70% to 80% of cases, the nodules prove to be benign and thus the surgery was unnecessary. The GEC helps physicians reduce the number of unnecessary surgeries by employing a proprietary 1
    '/>"/>

    SOURCE Veracyte
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Veracyte, Inc. to Announce Third Quarter 2013 Financial Results and Host Conference Call on Monday, November 25, 2013
    2. Veracyte, Inc. Announces Pricing of Initial Public Offering
    3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
    4. Golden Meditech Announces 2013 / 2014 Interim Results
    5. iHealth Announces Results of AHA Walking Challenge
    6. Unilife Announces Results of 2013 Annual General Meeting
    7. Hanger Announces Appointment of Christopher B. Begley to Board of Directors
    8. CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013
    9. Array BioPharma Announces Management Team Change
    10. Hill-Rom Holdings, Inc. Announces First Quarter 2014 Dividend
    11. Argos Therapeutics Announces Additional $17.5 Million Of Series E Financing Bringing Total Commitment To $60 Million
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... announced that they have entered into an ... proprietary sd-rxRNA® technology for use in developing ... the potential to result in novel, more ... could be a significant step toward personalized ...
    (Date:3/27/2015)... 27, 2015  Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on ... announces the reporting of data from a single ... Injection with the Delcath Hepatic Delivery System (Melphalan/HDS) ... the Society of Surgical Oncology (SSO) Annual Meeting ...
    (Date:3/26/2015)... 2015  The Burzynski Research Institute, Inc. (BRI) announced ... by the Department of Surgery at Kurume University ... have been published. The study, a randomized non-blinded ... as post-operative adjuvant therapy with and without Antineoplastons ... A total of 65 patients, ...
    Breaking Medicine Technology:RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
    ... Reportlinker.com announces that a new ... its catalogue: Pharmaceutical ... Infrastructure Overview: Pharma innovates, diversifies and ... profits http://www.reportlinker.com/p0484917/Pharmaceutical-Key-Trends-2011----Pharmaceutical-Industry-Infrastructure-Overview-Pharma-innovates-diversifies-and-contains-cost-in-order-to-grow-profits.html ...
    ... Simcere Pharmaceutical Group (NYSE: SCR ), a ... marketing of branded generic and proprietary pharmaceuticals in China, ... results for the first quarter ended March 31, 2011 ... in the United States. Simcere,s management will host an ...
    Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits 4Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011 2
    (Date:3/28/2015)... March 28, 2015 Genomic medicine experts ... mesothelioma, revealing, for the first time, key information for ... to read the newly posted story on the ... University of British Columbia, the British Columbia Cancer Agency, ... to reveal underlying molecular alterations and mutations that can ...
    (Date:3/28/2015)... Lately the student-athlete experience has ... proposals around the NCAA. In a March episode of ... across a spectrum of universities and sports shed light ... special panel consists of athletes who have competed for ... track and field, baseball, and volleyball. They discuss the ...
    (Date:3/28/2015)... Mirada, CA (PRWEB) March 28, 2015 ... ear, nose and throat disorders, are now ... is a common issue which is characterized by the ... Affecting 1 in 5 people, tinnitus is a prevalent ... disorder and while it is non-fatal, tinnitus can impede ...
    (Date:3/28/2015)... March 28, 2015 Designers and Professionals ... overlay entitled Scratches 5K from Pixel Film Studios. , ... to any media inside Final Cut Pro X” Said ... saves time and is an effective tool for any ... Overlay Scratches 5K's intuitive grunge overlays. Simply drag title ...
    (Date:3/28/2015)... NY (PRWEB) March 28, 2015 ... of dietary supplements announces the release of their ... was shown in two randomized, double-blind, placebo-controlled clinical ... and waist and hip size. MuffinStop™ is a ... indicus and Garcinia mangostana, fused together to create ...
    Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
    ... WASHINGTON, D.C., October 5, 2011 The Merck ... than $4 million in funding to implement the ... Symptoms (CHAMPS) partnership in five non-profit, Federally Qualified ... (CHC) is designed to demonstrate how asthma management ...
    ... (October 4, 2011)In a new study led by Fox ... have found that Gleason scores determined by pathologists at ... of recurrence than Gleason scores from referring institutions. ... Meeting of the American Society for Radiation Oncology on ...
    ... new study from the University of Adelaide shows the parents of ... some form of cardiovascular disease. PCOS is a hormonal disorder ... one of the most common endocrine disorders in women and a ... with PCOS are more likely to have any form of cardiovascular ...
    ... HealthDay Reporter , TUESDAY, Oct. 4 (HealthDay News) -- Heart ... just as well if they are released the same day as ... research shows. "[Discharging patients the same day] wasn,t associated ... lead author of a study appearing in the Oct. 5 issue ...
    ... Oct. 5 (HealthDay News) -- Three hours of vigorous exercise ... 22 percent, a new study suggests. The Harvard School ... of that decreased risk was due to the beneficial effects ... (HDL) cholesterol. The findings were published Oct. 4 the ...
    ... (HealthDay News) -- ,A common structural variation in the brain ... details of past events and to distinguish real events from ... report. The study included 53 healthy adults who underwent ... a fold at the front of the brain called the ...
    Cached Medicine News:Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 2Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 3Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 2Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 3Health News:Overnight Stay May Not Be Necessary for Stenting: Study 2Health News:Overnight Stay May Not Be Necessary for Stenting: Study 3Health News:MRI Study Unfolds Clues to Memory 2